StreetAlpha
13F holdings · Q3 2026

Foresite Capital Management VI

West Hollywood, CA · files as Foresite Capital Management VI LLC
Know the moment Foresite Capital Management VI filesYou follow Foresite Capital Management VI An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 2013341

Foresite Capital Management VI reported 22 stocks worth $566M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are CGON (26.4%), KRSA (8.1%) and LTGO (6.5%). Compared with Q2 2026, the fund opened new positions in KRSA, LTGO and OBX, added to DNLI, AGIO and AVBP, trimmed CGON and HNGE and sold out of CLDX, RACC and KLRA.

Latest filing: what Foresite Capital Management VI did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
4 new5 added2 trimmed5 sold outBought about $120M · sold about $88.5M
New 4
Added 5
Trimmed 2
Sold out 5
  • CLDX$32.7M
  • Atai Beckley NV$14.5M
  • Crinetics Pharmace$7.9M
  • RACC$3.2M
  • KLRA$826K

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$566M−11.9% vs last quarter
Stocks held224 new · 5 sold out
Top 5 weight53.2%fairly concentrated
Turnover37%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
CGON
CG Oncology Inc
$150M26.4%2.1M−260K (−11%)8 of 8
2
KRSA
Korsana Biosciences Inc
$45.8M8.1%1.4MNew position1 of 8
3
LTGO
Latigo Biotherapeutics
$36.8M6.5%2.2MNew position1 of 8
4
SPTX
Seaport Therapeutics Inc
$35.9M6.3%1.8MNo change2 of 8
5
DNLI
Denali Therapeutics Inc
$33.4M5.9%1.6M+221K (+16%)5 of 8
6
PBLS
Parabilis Medicines Inc Com
$32.3M5.7%999KNo change2 of 8
7
ALMS
Alumis Inc
$31.4M5.5%4.2MNo change8 of 8
8
AGIO
Agios Pharmaceuticals Inc
$27.5M4.9%827K+42K (+5%)4 of 8
9
VSTM
Verastem Inc
$25.3M4.5%3.1MNo change6 of 8
10
GHRS
GH Research PLC
$22.1M3.9%940KNo change3 of 8
🔒 12 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
CLDX
Celldex Therapeutics Inc
$32.7M880K
ATAI BECKLEY NV
$14.5M2.8M
CRINETICS PHARMACEUTICALS IN
$7.9M212K
RACC
Research Alliance Corp Iii Ord Shs Cl A
$3.2M300K
KLRA
Kailera Therapeutics Inc
$826K38K

Reported value

last 8 quarters
$224MQ4 '24
$183MQ1 '25
$178MQ2 '25
$259MQ3 '25
$331MQ4 '25
$460MQ1 '26
$643MQ2 '26
$566MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Foresite Capital Management VI 13F FAQ

What does Foresite Capital Management VI own?

Foresite Capital Management VI reported 22 stocks worth $566M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are CGON (26.4%), KRSA (8.1%) and LTGO (6.5%). The table above lists every position in the filing (the top 10 without an account).

What did Foresite Capital Management VI buy and sell in Q3 2026?

Compared with Q2 2026: 4 new positions, 5 added to, 2 trimmed and 5 sold out. New positions include KRSA, LTGO and OBX. It sold all of CLDX, RACC and KLRA.

When will Foresite Capital Management VI file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Foresite Capital Management VI's portfolio worth?

The Q3 2026 filing reports $566M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.